NCT05662345View on ClinicalTrials.gov

ACT-MBC: A Study of Circulating Tumor Cells (CTCs) in Metastatic Breast Cancer (MBC)

Active, not recruitingOBSERVATIONAL
Enrollment

65

Participants

Timeline

Start Date

December 12, 2022

Primary Completion Date

October 15, 2025

Study Completion Date

October 30, 2026

Conditions
Metastatic Breast Cancer
Interventions
DIAGNOSTIC_TEST

CellSearch Circulating Tumor Cells

Serial CTC enumeration

Trial Locations (4)

54703

MCHS Eau Claire, Eau Claire

55905

Mayo Clinic, Rochester

56001

Mayo Clinic Health System Mankato, Mankato

56007

Mayo Clinic Health System Albert Lea, Albert Lea

Sponsors

Collaborators (1)

Medex15
All Listed Sponsors
collaborator

Medex15

INDUSTRY

lead

Menarini Silicon Biosystems, INC

INDUSTRY